FindMyKOL
Clinical trialNCT01681823CompletedPhase 2Interventional

Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA

SponsorEcoNugenicsEnrollment60Prostatic Neoplasms
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To determine if the oral administration of PectaSol-C Modified Citrus Pectin (MCP) is effective at improving Prostate Specific Antigen (PSA) kinetics in men with biochemical relapsed prostate cancer and serial increases in PSA levels. Also, documentation of any side effects or benefits within parameter of the study is included.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Daniel Keizman, MD

    Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center

    Principal Investigator
    clinicaltrials.gov ↗
  • Isaac Eliaz, MD, LAc, MS

    Amitabha Medical Clinic and Healing Center

    Study Director
    clinicaltrials.gov ↗
  • Moshe Frenkel, MD

    Clinical Associate Professor, University of Texas

    Study Chair
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Israel
  • Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center, Tshernichovsky 59,

    Kfar Saba, Israel

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2013
Primary completion
31 Jan 2020
Completion
31 Jan 2020
Last update posted
29 Jan 2020
Registered enrollment
60
Registry id
NCT01681823
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.